Deutsch
English
Français
Español
Italiano
Svenska
Čeština
Nederlands
Русский
Українська
Polski
Anastrozole is a nonsteroidal aromatase inhibitor used in bodybuilding to control Estradiol during cycles that include aromatizing compounds. This is most commonly relevant when Testosterone is used, since part of it is converted into Estradiol under the action of the aromatase enzyme.
At the same time, Anastrozole is not a mandatory addition to every cycle. Its purpose is to correct excessive aromatization when it actually becomes a problem, rather than being used in advance simply because Testosterone is present in the protocol.
How Anastrozole works: aromatase and Estradiol control
Aromatase is an enzyme that converts part of certain androgens into estrogens. During a Testosterone cycle, more substrate becomes available for this process, so in some men Estradiol rises noticeably together with Testosterone.
Anastrozole reversibly inhibits aromatase and reduces the formation of new estrogens. It does not remove Estradiol that is already present in the body and does not act as an estrogen receptor blocker.
This is why Anastrozole is used to manage the intensity of aromatization. The degree of suppression required in a particular person cannot be predicted in advance based only on the Testosterone dosage.
Anastrozole during a Testosterone cycle: when Estradiol control becomes relevant
An increase in Estradiol during a Testosterone cycle is expected in itself. The important question is how pronounced that increase becomes and whether it is accompanied by changes that actually require intervention.
In practice, attention is paid to a combination of factors: the laboratory Estradiol level, pronounced water retention, an increase in blood pressure associated with it, tenderness or thickening in the breast area, and changes in libido and sexual function.
A single symptom does not establish the cause. For example, reduced libido can occur in very different hormonal states. This is why the approach “a symptom appeared — add Anastrozole” can easily lead to unnecessary or excessive suppression of aromatase.
The higher the amount of Testosterone and other aromatizing components in a cycle, the more relevant E2 monitoring becomes. However, two people using the same protocol can still differ considerably in Estradiol levels and in their need for an aromatase inhibitor.
Examples of common cycles: when Anastrozole may be relevant
The number of compounds in a cycle by itself says nothing about how much Anastrozole may be needed. It is more important to understand which substances can aromatize and which effects of a particular compound can easily be mistaken for high Estradiol.
| Example cycle | What should be considered | Role of Anastrozole |
| Testosterone | Part of Testosterone is converted into Estradiol | May be used when aromatization is genuinely excessive |
| Testosterone + Boldenone | Testosterone usually remains the main source of E2, but Boldenone has its own complex aromatization profile | The amount of Anastrozole cannot be reliably calculated from the Testosterone dosage alone — blood tests are especially useful |
| Testosterone + Nandrolone | Testosterone aromatizes, while Nandrolone also has progestogenic activity | Anastrozole controls aromatization but does not automatically solve every issue involving libido, breast tissue or other hormonal symptoms |
| Testosterone + Oxymetholone | Oxymetholone does not classically aromatize, but it can cause water retention and estrogen-like effects | Increasing Anastrozole simply because water retention has appeared during the cycle is not appropriate |
| Testosterone + Stanozolol or Oxandrolone | Stanozolol and Oxandrolone do not aromatize themselves | The need for Anastrozole is determined primarily by the response to Testosterone, not by the fact that a second compound has been added |
| Testosterone + Drostanolone | Drostanolone does not aromatize | It is not an automatic replacement for an aromatase inhibitor if E2 is genuinely elevated because of Testosterone |
| Testosterone + Trenbolone | Trenbolone does not aromatize but can complicate the interpretation of libido, well-being and other symptoms | Anastrozole affects only the aromatization of compounds in the cycle, not the effects of Trenbolone itself |
The more complex the protocol becomes, the less reliable correction based only on “external signs” becomes. Water retention, libido problems or changes in well-being do not by themselves prove that the aromatase inhibitor should be increased.
How Estradiol affects well-being, recovery and training results
Estradiol performs normal physiological functions in men. It is relevant to sexual function, bone tissue, the vascular system and overall well-being, so treating it only as an unwanted by-product of Testosterone is incorrect.
When Estradiol is excessively high during a cycle, possible effects include water retention, a more “watery” appearance, breast tenderness and changes in sexual function. In some athletes, additional water retention may also be accompanied by higher blood pressure and poorer overall well-being.
On the other hand, excessive suppression of Estradiol can also reduce the quality of the cycle. Sexual function, mood and comfort during heavy training may worsen.
For performance and results, the goal is therefore not simply the lowest possible E2 value, but a normal functional state without pronounced signs of either excess or deficiency.
How Anastrozole is used: dosage, half-life and adjustment based on blood tests
In nonmedical sports practice, a range of around 0.25–0.5 mg of Anastrozole every other day is commonly seen. An amount of around 1 mg every other day already represents substantially stronger aromatase suppression and requires more justification.
It is important not to treat a 1 mg tablet as automatically being the correct single dose. This is simply the dosage form of the product. This is why tablets are often split when a smaller amount of active ingredient is required.
The half-life of Anastrozole is approximately 46–50 hours. The compound continues to act for several days, so repeatedly changing the amount every one or two days makes it much harder to understand the individual response.
How to interpret Estradiol during a cycle
The phrase “adjust Anastrozole based on bloodwork” does not mean that it is enough to check whether the number falls within the laboratory reference range. A reference interval describes results from a particular population and is not a specifically established target range for men using AAS nonmedically.
There is also no single evidence-based number for an “ideal E2” in AAS users that applies equally to everyone regardless of Testosterone level, cycle composition and individual response.
The measurement method also matters. Estradiol in men is present at relatively low concentrations, where standard immunoassays may be less accurate. More sensitive LC-MS/MS-based methods are better suited for measuring low male E2 levels. If trends are being monitored, it is preferable to use the same laboratory and the same method.
Units of measurement must also be checked carefully. One laboratory may report Estradiol in pg/mL, while another may use pmol/L. These numbers cannot be compared directly without conversion.
A single result also does not establish the cause of poor well-being. For example, reduced libido may be related to Estradiol, Prolactin, other compounds, sleep quality, psychological state or the overall load of the cycle.
In practice, looking at the trend is more useful: what E2 was before the protocol was changed, what changed after adjusting Anastrozole, and whether the laboratory changes matched a real change in symptoms.
Therefore, rather than constantly searching for one “correct number,” it is usually clearer to change one factor at a time and then reassess the result under comparable conditions.
Anastrozole in the Dinespower range
Dinespower offers two products with the same Anastrozole content — 1 mg per tablet. They are comparable in terms of active ingredient and concentration, so the choice mainly depends on brand preference.
Arimimed 1 by Deus Medical contains 1 mg of Anastrozole per tablet. The tablet can be used whole or split when a smaller amount of active ingredient is required for Estradiol control.
Anastrozole by Astera Labs also contains 1 mg of Anastrozole per tablet. Therefore, in terms of concentration and the general logic of use, the two options are similar.
Anastrozole during cutting: water, definition and fat
If high Estradiol is accompanied by water retention, correcting it may make the physique look less “watery” and may slightly reduce body weight through loss of retained water.
This has nothing to do with burning body fat. Anastrozole does not create a calorie deficit and does not make the body use subcutaneous fat more quickly.
Therefore, using an aromatase inhibitor only for a drier appearance without signs of excessive aromatization is a poor reason to add it.
Side effects of Anastrozole and the risk of excessively low Estradiol
One of the main problems with Anastrozole use in bodybuilding is suppressing aromatase too strongly. This is especially easy to do when the compound is taken prophylactically or when the amount is repeatedly increased based only on subjective symptoms.
Possible signs of excessively low Estradiol include:
- reduced libido and poorer erectile function;
- joint discomfort;
- worsening mood and overall well-being;
- unfavorable changes in the lipid profile;
- with prolonged and pronounced deficiency, negative effects on bone tissue.
Anastrozole itself is also not a completely neutral compound. In medical use, musculoskeletal complaints, headache, changes in liver markers and other adverse reactions have been described.
If well-being worsens after starting Anastrozole or increasing the amount, adding even more of it based only on symptoms is not logical. It is more useful first to check in which direction Estradiol has actually changed.
Anastrozole and Tamoxifen: why are they used together?
Anastrozole and Tamoxifen act on different parts of the estrogen system. Anastrozole reduces the formation of Estradiol by inhibiting aromatase. Tamoxifen does not directly reduce the Estradiol concentration, but blocks estrogen action in certain tissues, including breast tissue.
Because of this, the situations in which they are used are different. With systemically elevated E2, the role of Anastrozole is to reduce its formation. Tamoxifen is more often discussed when blocking estrogen action specifically in breast tissue is especially important.
There is also a practical interaction to consider: when used together, Tamoxifen reduced Anastrozole concentrations in the blood by approximately 27%. This does not mean that the difference should automatically be compensated for by increasing the Anastrozole dose, but the interaction should be taken into account when evaluating the result.
If high E2 and breast-related symptoms appear at the same time, it is more useful to separate the two tasks — controlling the overall Estradiol level and acting on a specific tissue — rather than trying to solve both by randomly increasing both compounds.
Anastrozole after a cycle and during PCT
Anastrozole does not stimulate recovery of the body’s own Testosterone production. Therefore, by itself it does not perform the main role of PCT and should not automatically be carried over from the cycle into the recovery period.
However, the last injection and the end of aromatization are not the same thing either. After long Testosterone esters, the hormone remains in the body for some time and continues to provide substrate for Estradiol formation.
As the level of exogenous Testosterone declines, the need for aromatase inhibition also changes. An amount of Anastrozole that was used during the main part of the cycle may later become excessive.
SERM compounds used in the context of recovery work through a different mechanism and serve a different purpose. For this reason, whether Anastrozole should be continued after the cycle is assessed separately, taking into account the esters used, the time since the last injection and laboratory results.
Main conclusions on using Anastrozole during a cycle
Anastrozole makes sense when excessive aromatization genuinely requires control during a cycle. The fact that Testosterone is being used does not automatically mean that an aromatase inhibitor is necessary.
When evaluating Estradiol, symptoms and whether a result falls within a laboratory reference range are not the only factors that matter. The measurement method, units, cycle composition and the change in the value relative to previous results should also be considered.
If adjustment is genuinely required, it is clearer to change one factor at a time and then check the result than to constantly modify Anastrozole use according to subjective well-being. This approach allows E2 to be controlled with fewer unnecessary interventions and makes it easier to understand the individual response to the cycle.
